Three Insider-Favored Growth Stocks: Precigen, Upstart Holdings, and Karman Holdings.

Precigen, a biopharmaceutical company, has high insider ownership of 12.5% and is forecasting 39.6% annual revenue growth, outpacing the US market. Despite recent shareholder dilution and volatility, the company trades at a significant discount to its estimated fair value. Precigen's path to profitability in three years aligns with high insider ownership interests. Other insider-favored growth stocks include Upstart Holdings, Karman Holdings, and Enovix.